Problem is it isn't "PolyNovo’s T1D cure ambitions" unless they buy Beta Cell ( which they previous did with Greenwood/Burton's company that developed BTM). PNV are just a supplier of the mesh in my understanding.
PolyNovo Limited (PolyNovo or Company) will host an investor update webcast, to be streamed live on Friday 16 May at 10.00am AEST, page-10
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
-0.030(2.55%) |
Mkt cap ! $791.0M | |||
| Open | High | Low | Value | Volume |
| $1.17 | $1.18 | $1.15 | $2.259M | 1.955M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 23457 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.15 | 55555 | 1 |
View Market Depth
| Last trade - 16.10pm 08/08/2025 (20 minute delay) ? |
| PNV (ASX) Chart |